Lymphotoxin-alpha [lymfotoxin-alfa]
- Terms
-
lymfotoxin
lymfotoxin-alfa3
TNF-beta
-
alpha-Lymphotoxin
Lymphotoxin
Lymphotoxin-alpha3
Soluble Lymphotoxin-alpha
TNF Superfamily, Member 1
TNF-beta
Tumor Necrosis Factor Ligand Superfamily Member 1
Tumor Necrosis Factor-beta
A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR.
- Annotation
- for "lymphocytotoxin" use CYTOTOXINS and LYMPHOCYTES
- DUI
- D008233 MeSH Browser
- CUI
- M0012828
- History note
- 2007 (1974-1977); for TUMOR NECROSIS FACTOR-BETA & TNF-BETA use TUMOR NECROSIS FACTOR 1988-1989
- Public note
- 2007; was LYMPHOTOXIN 1990-2006; LYMPHOTOXIN-ALPHA was indexed under LYMPHOTOXIN see LYMPHOTOXINS 1978-1989; see LYMPHOTOXIN 1974-1977; for TUMOR NECROSIS FACTOR-BETA & TNF-BETA see TUMOR NECROSIS FACTOR 1988-1989
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood 2
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics 9
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
C9RP protein, human Chemical MeSH Browser
LTA protein, human Chemical MeSH Browser
anti-treponemal lymphotoxin Chemical MeSH Browser
lymphocyte effector molecules Chemical MeSH Browser
mutein 2 Chemical MeSH Browser